QLUCORE AB During the project
The targeted cancer disease areas are important because both cancer types have multiple changes on the RNA level that can be utilized to improve diagnosis and treatment. However, today this information is not fully used to provide the right therapy for the right patient. The project aims to change this.
The recognition from the expert review panels of our solutions and the addressed clinical need further strengthens the belief in our strategic direction and our focus on solutions based on RNA. RNA-based solutions are gaining momentum, allowing for cancer classification using gene fusions and gene expression signatures. RNA-seq can reliably detect gene fusions and measure gene expression levels, thereby providing more insights into cancer biology.
The grant will strengthen the financial position of
For a medical device to be used in healthcare diagnostics, IVDR regulations require the device to have CE marking. For this project
"We are clearly at the forefront of RNA-seq based modern clinical diagnostics. To receive this grant strengthens
The intended customers are clinical laboratories in
© Modular Finance, source
